EP0031/A400 is being developed jointly by Ellipses in a global clinical phase 1/2 trial under the name EP0031 (NCT05443126) and Kelun Biotech (6990.HK) in China under the name A400 (NCT05265091).

In September, the Centre discharged Puja Khedkar from the IAS, after she was accused of faking her identity to get more attempts in the UPSC examination.